Non-invasive ventilation (NIV) is a way of supporting breathing using pressurized air delivered through a face mask, without placing a tube into the windpipe. It works by pushing air at higher-than-normal pressure into the lungs during each breath, reducing the effort your breathing muscles have to do and improving the exchange of oxygen and carbon dioxide. NIV is used in hospitals for acute breathing emergencies and at home for chronic conditions like COPD and sleep apnea.
How NIV Supports Breathing
When you breathe normally, your diaphragm and chest muscles contract to expand the lungs and pull air in. In respiratory failure, these muscles are overworked or weakened, and the lungs may not inflate fully. NIV takes over part of that work by delivering air at pressures above normal atmospheric pressure. This expands the lungs, increases the volume of each breath, and significantly reduces strain on the diaphragm and other breathing muscles. You exhale passively as the lungs naturally recoil.
Beyond the immediate relief, NIV also opens up collapsed areas of the lung that aren’t participating in gas exchange. By recruiting these areas, it improves how well oxygen gets into the blood and carbon dioxide gets out. In people who use NIV regularly over time, three additional benefits emerge: chronically fatigued breathing muscles get a chance to rest and recover strength, improved lung expansion makes the lungs more compliant (easier to inflate) even during periods off the machine, and the body gradually resets its sensitivity to carbon dioxide, reducing the tendency to under-breathe during the day.
CPAP vs. Bilevel Pressure
NIV comes in two main forms, and they work differently. CPAP (continuous positive airway pressure) delivers one constant pressure throughout the entire breathing cycle. It doesn’t actively push air into your lungs during inhalation. Instead, it acts as a splint, holding the airways open. This makes CPAP ideal for obstructive sleep apnea, where the upper airway collapses during sleep, and for acute situations where collapsed lung tissue needs to be reopened, like fluid buildup in the lungs from heart failure.
Bilevel pressure (often called BiPAP, a brand name that’s become a catch-all term) delivers two different pressures: a higher one when you breathe in and a lower one when you breathe out. The higher inspiratory pressure does the actual work of ventilation, helping air flow into the lungs. The lower expiratory pressure keeps airways and small air sacs open between breaths, preventing collapse and helping clear exhaled gas. This two-pressure approach makes bilevel NIV the preferred choice when the core problem is a buildup of carbon dioxide in the blood, as happens during severe COPD flare-ups or in people with weak breathing muscles from neuromuscular disease or chest wall deformities.
When NIV Is Used
The most well-established use of bilevel NIV is in COPD exacerbations that cause the blood to become too acidic from carbon dioxide retention. Guidelines from the European Respiratory Society and American Thoracic Society recommend bilevel NIV when blood pH drops to 7.35 or below, carbon dioxide levels exceed 45 mmHg, and the breathing rate stays above 20 to 24 breaths per minute despite standard medications. In this setting, NIV can prevent the need for intubation and mechanical ventilation in the ICU.
For acute heart failure with fluid in the lungs, both CPAP and bilevel NIV reduce the likelihood of needing a breathing tube. A meta-analysis of randomized trials found that CPAP reduced mortality by about 36% compared to standard oxygen therapy, and bilevel pressure ventilation reduced it by roughly 27%. Both forms also led to faster improvements in oxygen levels.
In the home setting, NIV is used long-term for people with chronic respiratory failure from COPD, neuromuscular conditions, or severe obesity. Recent U.S. coverage guidelines for COPD patients require documented carbon dioxide levels of at least 52 mmHg and ongoing use of at least 4 hours per day on 70% or more of days each month. Follow-up within six months should show either normalization of carbon dioxide, stabilization, a 20% reduction from baseline, or improvement in symptoms.
Mask Types and Comfort
The mask is the physical connection between you and the machine, and choosing the right one matters for both comfort and effectiveness. The two main options are nasal masks and oronasal (full face) masks.
Nasal masks cover only the nose. They’re smaller, lighter, and generally rated as more comfortable. Bench testing has shown they’re more stable on the face and produce fewer timing mismatches between the machine’s airflow and your natural breathing rhythm. The trade-off is mouth leaks: if your mouth falls open during sleep, pressurized air escapes and the support becomes less effective.
Oronasal masks cover both the nose and mouth, which eliminates the mouth leak problem and allows higher pressures to be delivered reliably. They’re the standard choice in hospitals during acute respiratory failure. The downsides are real, though. They can feel claustrophobic, they make it harder to talk or eat, and they concentrate pressure on the lower jaw, which can actually promote airway obstruction in some users. In bench studies, oronasal masks generated higher average air leaks (about 41 liters per minute versus 34 for nasal masks) and more breathing-timing mismatches.
Total face masks, which cover the entire face, exist as a third option for people who can’t tolerate either standard type, often because of facial shape or skin sensitivity around the nose bridge.
Who Should Not Use NIV
NIV requires a patient who is cooperative and able to protect their own airway. It is generally not appropriate for someone in respiratory arrest, someone who is agitated enough to need sedation, or someone in hemodynamic shock with very low blood pressure or a dangerously slow heart rate. Multiorgan failure is another situation where NIV is typically avoided in favor of intubation.
Interestingly, reduced consciousness from high carbon dioxide levels alone is not an absolute barrier. A large case series found no difference in outcomes between patients with and without carbon dioxide-related coma treated with NIV, though this requires close monitoring by an experienced team.
Recognizing When NIV Isn’t Working
Not everyone responds to NIV, and early recognition of failure is critical because delays in switching to invasive ventilation worsen outcomes. Clinicians use a scoring system called HACOR, which combines heart rate, blood acidity, level of consciousness, oxygen levels relative to the concentration being delivered, and breathing rate into a score from 0 to 25. A score above 5 at one hour after starting NIV indicates a high risk of failure, with a specificity of about 83%. In practical terms, if your breathing rate, heart rate, and oxygen levels haven’t improved within the first one to two hours, the clinical team will likely reassess the plan.
Common Side Effects
Most side effects of NIV are related to the mask and the pressure itself rather than to any systemic risk. Skin irritation or pressure sores on the nose bridge are common with prolonged use, particularly with oronasal masks that press firmly against the face. Nasal dryness and congestion are frequent complaints, usually managed with heated humidifiers built into the circuit. Some people swallow air during treatment, leading to bloating and stomach discomfort. Mask leaks around the edges can cause eye irritation from air blowing upward, and poorly fitting masks are one of the most common reasons people struggle with long-term NIV adherence.